Assorted Links

Assorted Links

Assorted Links

Thanks to Paul Sas and Gary Wolf.

Six Signs of Profound Stagnation in Health Care

In a recent interview, Tim Harford, the Underground Economist, said,

That’s what makes medicine such an effective academic discipline.

By “that” he meant certain methodologies, especially randomized experiments. I disagree with this assessment. My opinion is that health care is in a state of profound stagnation, unable to make much progress on major problems.

Here are six signs of the stagnation in health care (by which I mean everything related to health):

1. The irrelevance of Nobel Prizes. Year after year, the Nobel Prize in medicine is usually given for research that is so far useless (e.g., teleomere research) or irrelevant to major health problems.

2. The obesity epidemic. Starting in 1980, obesity rates climbed fast. Thirty years later, doctors seem to know no more about how to cure obesity than in 1980. Low-fat diets, popular in the 1980s, are still popular! Low-carb diets are ancient — the Banting diet became popular in the 1860s.

3. Ancient treatments for depression still popular. SSRIs were introduced in 1988. Cognitive-behavioral therapy began in the 1980s, combining earlier ideas. Neither works terribly well — and notice how different they are.

4. The high cost of ineffective care. Americans pay much more for health care than people in other rich countries, yet American health is no better. All that new technology that Americans are paying for isn’t helping. In an article complaining about our education system, Joel Klein, the former head of New York City schools, wrote, “unlike in health care . . . in education, despite massive increases in expenditure, we don’t see improved results.” Actually, that’s exactly what we see in health care when we compare America to other countries. Tyler Cowan makes this point in The Great Stagnation.

5. Statins. A defender of modern medicine would claim that statins were an important innovation. They are heavily prescribed, yes. Yet in recent tests they have been stunningly ineffective — so much so that the earlier favorable evidence has been questioned.

6. The stagnation has become invisible — the normal state of affairs. Allowing Harford to make that comment. Harford, like Dr. Ben “Bad Science” Goldacre (whom Harford praises), believes you judge science by whether it follows certain rules. By making various rules (e.g., the need for placebo controls) and then following them, medical researchers have drawn attention — at least Harford’s and Goldacre’s — away from lack of progress. They’re making progress, they say, because they’re following self-imposed rules. Well, what if the rules make things worse? (For example, placing high value on placebo controls may draw attention away from non-pill treatments.) Better to judge by results.

What do you think are the clearest signs of health-care stagnation — if you agree with me about this?

Assorted Links

  • This study suggests calcium supplements are dangerous. They can raise your risk of heart attacks. There are probably better ways to reduce osteoporosis.
  • Conventional clinical trials overstate the value of drugs, says this paper. One reason is that they compare drug to placebo. In clinical practice, the choice is never drug or placebo; it is drug or other treatment (usually a different drug). “We need to put an end to this kind of gaming of the system” — a system in which standards of evidence grossly favor drug companies at the expense of everyone else.
  • Doctors use patient’s need for help to remove bad reviews. “The doctors simply make their patients sign a contract handing over the copyright of any review they might publish online afterwards. So, if the patients post any bad review, the company is able to send a DMCA notice demanding that the content be removed immediately.”
  • The end of mercury amalgam in dentistry.
  • paleolithicdiet.com, a new site from the founder of Paleohacks

Roche is Deceptive and Evasive

In an article about Tamiflu, an anti-flu drug developed by Roche, Helen Epstein writes:

[Non-Roche researchers] noticed yet more discrepancies between the articles that had appeared in scientific journals and Roche’s internal documents, many concerning the drug’s safety. According to published articles, no potentially drug-related serious side effects—or “serious adverse events” as they are called—were reported in the papers describing two Roche-sponsored clinical trials in which 908 people took Tamiflu; but according to Roche’s unpublished documents, three “serious adverse events” that were possibly related to Tamiflu occurred in these trials.

In 2008, an article in the journal Drug Safety, signed by a group of Roche authors, claimed that rats and mice, both given a very high dose of Tamiflu, showed no ill effect. But according to documents submitted to the Japanese Ministry of Health, Labor, and Welfare by Chugai, the Japanese Roche subsidiary, the exact same dose of Tamiflu killed more than half of the animals. As they died, the rats exhibited many of the same central nervous system symptoms that Hama had described in his case series on the Japanese children.

That’s deceptive. Here’s evasive:

“Do the ‘full study reports’” containing all five modules exist?” I asked my correspondent at Roche. “A simple ‘yes’ or ‘no’ answer will do.” In reply, she did not say “yes” or “no,” but repeated her claim that the Cochrane group had all the information it needed to analyze the Tamika studies.

This sort of thing is why I don’t trust drug companies. They’re dishonest again and again, with trivial consequences. Epstein’s article would have been even better had she given the names of the Roche employees she criticizes (the authors of the deceptive studies, the evasive correspondent).

Assorted Links

Thanks to Craig Fratrik, Tom George and Sean Curley.

Statins Reduce Cholesterol But Not Heart Disease Progression

The notion that high cholesterol (more specifically, high “bad” — LDL — cholesterol) causes heart disease may be as widely accepted as the notion that humans have caused dangerous global warming. It is much easier to test, however. An excellent study published in 2006 compared two groups of people at risk for heart disease: those given a high dose of statins and those given a low dose. The high dose reducd LDL cholesterol levels; as it was meant to; the low dose did not. But there was no effect on coronary heart disease progression. After a year of statins, persons in both groups had increased their coronary artery calcification score by the same amount — about 25%. Totally contradicting the cholesterol hypothesis.

Regular readers of this blog may remember that after a year of eating butter (half a stick per day), my coronary artery calcification score decreased 24%. Because increases of about 25% are the norm, my score was about 50% less than expected. Decreases are very rare, I was told.

Thanks to Hyperlipid. Statin side effects.

Terrific Essay by Cory Doctorow

I highly recommend this editorial by Cory Doctorow about the dangers of allowing a small number of people — such as big companies — to control how everyone’s computer, smart phone, etc., operates. I especially like his conclusion, modeled on Isaac Asimov’s T hree Laws of Robotics:

But we’ll only arrive at those solutions once we stop reflexively demanding limits on the general functionality of a PC and a network — and the sooner we do, the sooner we’ll legitimize a technology world whose first rule is “Obey your owner” and whose second rule is “Protect your owner’s interests”.

In case it isn’t obvious, self-experimentation and personal science increase your control of your body, just as Doctorow wants each person to control the technology they own. Without self-experimentation and personal science — and their ability to solve health problems in a way best for you — you give control over your body to doctors, drug companies, medical school professors, nutritionists, alternative-medicine advocates, and many others whose interests differ from yours. Often the difference is large — drug companies prefer expensive dangerous solutions to cheap safe ones.